vimarsana.com
Home
Live Updates
Biogen Announces Topline Results from the Tofersen Phase 3 :
Biogen Announces Topline Results from the Tofersen Phase 3 :
Biogen Announces Topline Results from the Tofersen Phase 3
In the Phase 3 VALOR study, the primary endpoint as measured by the Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R) did not reach...
Related Keywords
Cambridge ,
Cambridgeshire ,
United Kingdom ,
United States ,
American ,
Timothy Miller ,
Walter Gilbert ,
Charles Weissmann ,
Heinz Schaller ,
Alfred Sandrock Jr ,
Ashleigh Koss ,
Mike Hencke ,
Kenneth Murray ,
Head Of Research ,
Linkedin ,
Twitter ,
Ionis Pharmaceuticals Inc ,
Biogen Inc ,
Washington University School Of Medicine ,
Nasdaq ,
American Neurological Association ,
Exchange Commission ,
Youtube ,
Facebook ,
Washington University School ,
Alfred Sandrock ,
Open Label Extension ,
Slow Vital Capacity ,
Neurological Association ,
Annual Meeting Presentation ,
Ionis Pharmaceuticals ,
Amyotrophic Lateral Sclerosis ,
Nobel Prize ,
Today Biogen ,
Private Securities Litigation Reform Act ,
Nasdaq Biib ,